"Fluocinolone Acetonide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glucocorticoid derivative used topically in the treatment of various skin disorders. It is usually employed as a cream, gel, lotion, or ointment. It has also been used topically in the treatment of inflammatory eye, ear, and nose disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732)
| Descriptor ID |
D005446
|
| MeSH Number(s) |
D04.210.500.745.432.370 D04.210.500.908.394
|
| Concept/Terms |
Fluocinolone Acetonide- Fluocinolone Acetonide
- Acetonide, Fluocinolone
- Fluortriamcinolone Acetonide
- Acetonide, Fluortriamcinolone
|
Below are MeSH descriptors whose meaning is more general than "Fluocinolone Acetonide".
Below are MeSH descriptors whose meaning is more specific than "Fluocinolone Acetonide".
This graph shows the total number of publications written about "Fluocinolone Acetonide" by people in this website by year, and whether "Fluocinolone Acetonide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluocinolone Acetonide" by people in Profiles.
-
Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024 Sep; 131(9):1107-1120.
-
Vitreous cytokine levels following the administration of a single 0.19?mg fluocinolone acetonide (ILUVIEN?) implant in patients with refractory diabetic macular edema (DME)-results from the ILUVIT study. Graefes Arch Clin Exp Ophthalmol. 2022 Aug; 260(8):2537-2547.
-
CHOROIDAL LESIONS UNRESPONSIVE TO FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN BIRDSHOT CHORIORETINOPATHY. Retin Cases Brief Rep. 2022 Jan 01; 16(1):56-58.
-
Effects of Long-Term DME Control With 0.2 ?g/Day Fluocinolone Acetonide Implant on Quality of Life: An Exploratory Analysis From the FAME Trial. Ophthalmic Surg Lasers Imaging Retina. 2020 11 01; 51(11):658-667.
-
Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration. Invest Ophthalmol Vis Sci. 2019 05 01; 60(6):2134-2139.
-
Impact of intravitreal pharmacotherapies including antivascular endothelial growth factor and corticosteroid agents on diabetic retinopathy. Curr Opin Ophthalmol. 2017 May; 28(3):213-218.
-
Long-term Effects of Intravitreal 0.19 mg Fluocinolone Acetonide Implant on Progression and Regression of Diabetic Retinopathy. Ophthalmology. 2017 04; 124(4):440-449.
-
Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol. 2000 Jun 01; 164(11):5970-80.